ADC Therapeutics SA
NYSE:ADCT
ADC Therapeutics SA
NYSE:ADCT
Price:
4.97 USD
6.2%
Market Closed
Updated:
Apr 24, 2024
ADC Therapeutics SA
Common Stock
Last
Value
3-Years CAGR
5-Years CAGR
|
ADC Therapeutics SA
Common Stock Peer Comparison
Comparables:
ACIU
CRSP
BSLN
IDIA
KURN
Competitive Common Stock Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Common Stock | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
ADC Therapeutics SA
NYSE:ADCT
|
Common Stock
$7.3m
|
CAGR 3-Years
5%
|
CAGR 5-Years
79%
|
CAGR 10-Years
N/A
|
|
|
AC Immune SA
NASDAQ:ACIU
|
Common Stock
CHf2.1m
|
CAGR 3-Years
12%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
|
CRISPR Therapeutics AG
NASDAQ:CRSP
|
Common Stock
$2.5m
|
CAGR 3-Years
3%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
|
Basilea Pharmaceutica AG
SIX:BSLN
|
Common Stock
CHf13.1m
|
CAGR 3-Years
3%
|
CAGR 5-Years
2%
|
CAGR 10-Years
3%
|
|
|
Idorsia Ltd
SIX:IDIA
|
Common Stock
CHf8.9m
|
CAGR 3-Years
11%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
|
Kuros Biosciences AG
SIX:KURN
|
Common Stock
CHf3.7m
|
CAGR 3-Years
-52%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
N/A
|
See Also
What is ADC Therapeutics SA's Common Stock?
Common Stock
7.3m
USD
7.3m
USD
Based on the financial report for Dec 31, 2023, ADC Therapeutics SA's Common Stock amounts to 7.3m USD.
What is ADC Therapeutics SA's Common Stock growth rate?
Common Stock CAGR 5Y
79%
79%
Over the last year, the Common Stock growth was 0%. The average annual Common Stock growth rates for ADC Therapeutics SA have been 5% over the past three years , 79% over the past five years .
You don't have any saved screeners yet
